disulfiram has been researched along with Graves Ophthalmopathy in 1 studies
Graves Ophthalmopathy: An autoimmune disorder of the EYE, occurring in patients with Graves disease. Subtypes include congestive (inflammation of the orbital connective tissue), myopathic (swelling and dysfunction of the extraocular muscles), and mixed congestive-myopathic ophthalmopathy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, X | 2 |
| Ye, H | 1 |
| Yang, S | 1 |
| Sha, X | 1 |
| Zhang, T | 1 |
| Chen, R | 1 |
| Xiao, W | 1 |
| Yang, H | 1 |
1 other study available for disulfiram and Graves Ophthalmopathy
| Article | Year |
|---|---|
Disulfiram Exerts Antifibrotic and Anti-Inflammatory Therapeutic Effects on Perimysial Orbital Fibroblasts in Graves' Orbitopathy.
Topics: Anti-Inflammatory Agents; Cells, Cultured; Disulfiram; Fibroblasts; Fibrosis; Graves Ophthalmopathy; | 2022 |